GlaxoSmithKline’s Prescription-Strength Fish Oil Drug, Lovaza Fails in Atrial Fibrillation Study

November 16, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CHICAGO, Nov 15 (Reuters) - Taking a high dose of fish oil does not prevent symptoms of atrial fibrillation, a common heart rhythm problem that can cause strokes, U.S. researchers said on Monday.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 2

GSK